Charles River Laboratories International (CRL) Change in Account Payables (2009 - 2025)

Charles River Laboratories International (CRL) has reported Change in Account Payables for 17 consecutive years, with -$37.9 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Change in Account Payables fell 427.84% year-over-year to -$37.9 million; the TTM figure through Dec 2025 stood at $2.9 million (up 120.1% YoY), while the FY2025 annual figure was $2.9 million, up 120.1% from the prior year.
• Change in Account Payables came in at -$37.9 million for Q4 2025 at Charles River Laboratories International, down from $24.5 million in the prior quarter.
• The five-year high for Change in Account Payables was $40.9 million in Q1 2022, with the low at -$41.3 million in Q2 2023.
• Average Change in Account Payables over 5 years is $521000.0, with a median of -$1.1 million recorded in 2023.
• The largest YoY upside for Change in Account Payables was 3818.66% in 2025 against a maximum downside of 528.03% in 2025.
• Year by year, Change in Account Payables stood at $33.5 million in 2021, then sank by 125.79% to -$8.6 million in 2022, then surged by 170.72% to $6.1 million in 2023, then slumped by 217.56% to -$7.2 million in 2024, then slumped by 427.84% to -$37.9 million in 2025.
• According to Business Quant data, Change in Account Payables over the past three periods registered -$37.9 million, $24.5 million, and -$9.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.